gip/glp-1 drugs Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements Curious how GLP-1 and GIP

Most GLP-1 attorneys work on contingency, meaning there is no upfront cost

Conclusions In this real-word study, GLP-1RA was associated with a lower risk of AF compared with DPP4i, but no difference compared with SGLT2i, suggesting that cardiovascular benefits of GLP-1RA use may extend to prevention for AF in patients with diabetes

Recent studies suggest that glucagon receptor signaling is disrupted in NAFLD, indicating that supra-physiological glucagon receptor agonism might represent a new NAFLD treatment target

They demonstrate that a murine model of diabetes is associated with the development of ER stress in beta cells

But for a lot of people, these meds are not just appropriate, theyre overdue

Type 1 Diabetics: GLP-1 medications are not effective for Type 1 Diabetes